Bristol-Myers Squibb Company (BMY) — Financial statements
Income statement, balance sheet, and cash flow for Bristol-Myers Squibb Company — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 48,194↓0.2% | 48,300↑7.3% | 45,006↓2.5% | 46,159↓0.5% | 46,385 | |
| Cost of Revenue | 15,592↓25.3% | 20,868↑6.2% | 19,649↓0.1% | 19,669↑0.2% | 19,624 | |
| Gross Profit | 32,602↑18.8% | 27,432↑8.2% | 25,357↓4.3% | 26,490↓1.0% | 26,761 | |
| Operating Expenses | ||||||
| R&D Expenses | 9,612↓1.7% | 9,782↑6.2% | 9,207↓2.2% | 9,411↓1.3% | 9,533 | |
| General & Administrative Expenses | 5,660↓11.1% | 6,365 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 1,584↑5.6% | 1,500 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 7,244↓7.9% | 7,865↑2.4% | 7,678↓1.7% | 7,808↑1.6% | 7,688 | |
| Other Expenses | 3,050↑2301.6% | 127 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 19,906↑12.0% | 17,774↑5.3% | 16,885↓1.9% | 17,219↓0.0% | 17,221 | |
| Total Costs & Expenses | 35,498↓8.1% | 38,642↑5.8% | 36,534↓1.0% | 36,888↑0.1% | 36,845 | |
| Operating Results | ||||||
| Operating Income | 12,696↑31.5% | 9,658↑14.0% | 8,472↓8.6% | 9,271↓2.8% | 9,540 | |
| Depreciation & Amortization | 3,860↓59.8% | 9,600↓1.6% | 9,760↓5.0% | 10,276↓3.8% | 10,686 | |
| EBITDA | 14,545↑359.1% | 3,168↓83.6% | 19,366↑0.8% | 19,221↓4.5% | 20,118 | |
| EBIT | 10,684↑266.1% | -6,432↓167.0% | 9,606↑7.4% | 8,945↓5.2% | 9,432 | |
| Interest & Other Income | ||||||
| Net Interest Income | -1,210↑37.9% | -1,947↓67.0% | -1,166↑5.4% | -1,232↑7.6% | -1,334 | |
| Interest Income | 300 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 1,510↓22.4% | 1,947↑67.0% | 1,166↓5.4% | 1,232↓7.6% | 1,334 | |
| Non-Operating Income | 2,012↓87.5% | 16,090↑1518.9% | -1,134↓447.9% | 326↑201.9% | 108 | |
| Other Income / Expenses | -3,368↑81.3% | -18,037↓56265.6% | -32↑97.9% | -1,558↓8.0% | -1,442 | |
| Income Before Tax | 9,328↑211.3% | -8,379↓199.3% | 8,440↑9.4% | 7,713↓4.8% | 8,098 | |
| Income Tax Expense | 2,272↑310.1% | 554↑38.5% | 400↓70.8% | 1,368↑26.2% | 1,084 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 7,056↑179.0% | -8,933↓211.1% | 8,040↑26.7% | 6,345↓9.5% | 7,014 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 7,053↑178.8% | -8,948↓211.5% | 8,025↑26.8% | 6,327↓9.5% | 6,994 | |
| Bottom-Line Net Income | 7,053↑178.8% | -8,948↓211.5% | 8,025↑26.8% | 6,327↓9.5% | 6,994 | |
| EPS (Basic) | 3.46↑178.5% | -4.41↓213.7% | 3.88↑30.6% | 2.97↓5.7% | 3.15 | |
| EPS (Diluted) | 3.45↑178.2% | -4.41↓214.2% | 3.86↑30.8% | 2.95↓5.4% | 3.12 | |
| Weighted Average Shares | 2,041↑0.7% | 2,027↓2.0% | 2,069↓2.9% | 2,130↓4.1% | 2,221 | |
| Weighted Average Diluted Shares | 2,041↑0.7% | 2,027↓2.5% | 2,078↓3.2% | 2,146↓4.4% | 2,245 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.